Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,430 | 119,302 | 85,230 | 85,347 | 94,036 |
| Marketable Securities | N/A | N/A | 2,208 | N/A | N/A |
| Receivables | 152 | 109 | 41,667 | 1,468 | 817 |
| Other current assets | 3,006 | 2,515 | 1,994 | 1,943 | 2,845 |
| TOTAL | $111,588 | $121,926 | $131,099 | $88,758 | $97,698 |
| Non-Current Assets | |||||
| PPE Net | 2,473 | 2,552 | 2,321 | 2,203 | 2,280 |
| Investments And Advances | 0 | 0 | 0 | 2,208 | 2,208 |
| Intangibles | 36,402 | 36,402 | 38,502 | 39,079 | 39,080 |
| Other Non-Current Assets | 157 | 157 | 157 | 157 | 158 |
| TOTAL | $39,032 | $39,111 | $40,980 | $43,647 | $43,726 |
| Total Assets | $150,620 | $161,037 | $172,079 | $132,405 | $141,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,301 | 6,570 | 6,039 | 4,237 | 3,981 |
| Other current liabilities | 115 | 115 | 115 | 115 | 115 |
| TOTAL | $5,416 | $6,685 | $6,154 | $4,352 | $4,096 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,399 | 18,111 | 18,012 | 29,832 | 17,113 |
| TOTAL | $29,731 | $29,443 | $30,105 | $29,832 | $29,434 |
| Total Liabilities | $35,147 | $36,128 | $36,259 | $34,184 | $33,530 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,645 | 69,640 | 69,556 | 69,556 | 69,556 |
| Common Shares | 91 | 91 | 91 | 91 | 91 |
| Retained earnings | -472,521 | -462,267 | -450,088 | -487,063 | -475,990 |
| Other shareholders' equity | 259 | 259 | 67 | 67 | 67 |
| TOTAL | $115,473 | $124,909 | $135,820 | $98,221 | $107,894 |
| Total Liabilities And Equity | $150,620 | $161,037 | $172,079 | $132,405 | $141,424 |